ADVFN US – Market Content Editor

GE Aerospace (NYSE:GE) said on Tuesday that it has agreed to acquire Consolidated Precision Products from private investment firms Warburg Pincus and Berkshire Partners for $11.75 billion. Consolidated Precision Products, or CPP, manufactures engineered castings and sub-assemblies for commercial aerospace and defence customers. The Cleveland, Ohio-based company employs approximately 6,600 people across more than 20…

Solaris Energy Infrastructure, Inc. (NYSE:SEI) shares rose 6% on Tuesday after the company increased its Adjusted EBITDA guidance for the third and fourth quarters of 2026 and issued an initial forecast for the first quarter of 2027. The company attributed the higher outlook to increased contributions from its core power services operations and performance from…

Intellia Therapeutics (NASDAQ:NTLA) shares rose 8% on Tuesday after the U.S. Food and Drug Administration accepted the company’s Biologics License Application for lonvoguran ziclumeran, or lonvo-z, for hereditary angioedema and granted it Priority Review. The FDA set a Prescription Drug User Fee Act target action date of March 10, 2027. The agency also advised Intellia…

Best Buy (NYSE:BBY) shares fell 2.2% in premarket trading after DA Davidson downgraded the consumer electronics retailer to Neutral from Buy and set a $95 price target. The firm cited valuation following a recovery in Best Buy’s share price, which had moved to within approximately 5% of its new target. According to the supplied information,…

Roivant Sciences (NASDAQ:ROIV) shares rose 22.0% in premarket trading after its Pulmovant subsidiary reported topline results from the Phase 2 PHocus study of mosliciguat in patients with pulmonary hypertension associated with interstitial lung disease, or PH-ILD. The results were presented at the European Respiratory Society International Congress 2026 by Professor Marc Humbert of Université Paris-Saclay.…

Ionis Pharmaceuticals (NASDAQ:IONS) shares fell 13.1% to $50.51 in premarket trading as investors continued to assess the Phase 3 trial result for pelacarsen, an RNA-targeted cardiovascular drug licensed to Novartis. Novartis disclosed on September 4 that the Phase 3 Lp(a)HORIZON study did not meet its primary endpoint. The trial enrolled more than 8,300 high-risk patients…

Biohaven Pharmaceutical (NYSE:BHVN) shares fell 1.9% to $15.40 in premarket trading after RBC Capital downgraded the company to Sector Perform from Outperform and lowered its price target to $19 from $23. RBC based the downgrade primarily on valuation following a recovery in Biohaven’s share price. According to the supplied information, the shares have risen approximately…

Amgen (NASDAQ:AMGN) shares fell 4.7% to $416.88 in premarket trading as investors assessed the implications of a Phase III trial result from Novartis involving an experimental Lp(a)-lowering treatment, alongside a downgrade from BMO Capital. Novartis announced on September 4 that pelacarsen, an investigational treatment designed to reduce lipoprotein(a), did not reduce the risk of cardiovascular…

Dyne Therapeutics (NASDAQ:DYN) shares fell 31.0% to $16.76 in premarket trading, compared with a previous close of $24.28. No official company announcement confirming a reason for the share-price movement had been identified in the supplied information at the time of writing. Without such confirmation, the cause of the decline remains unclear. The stock was trading…

Sigma Lithium (NASDAQ:SGML) shares fell nearly 12.0% in premarket trading after a Brazilian federal court ordered the suspension of environmental permits and mining operations at the company’s Grota do Cirilo complex in Minas Gerais. The injunction was issued on Friday by Judge Antonio Lucio Tulio de Oliveira Barbosa in connection with a civil lawsuit brought…